ClinicalTrials.gov
ClinicalTrials.gov Menu

Experience of Erlotinib in Patients With Advanced Non-Small Cell Lung Cancer (REALME)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01320501
Recruitment Status : Suspended (Difficulty in enrolling patients)
First Posted : March 22, 2011
Last Update Posted : May 13, 2016
Sponsor:
Information provided by (Responsible Party):
National Guard Health Affairs

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Suspended
  Estimated Primary Completion Date : August 2016
  Estimated Study Completion Date : August 2016